Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration (Q47749207)
scientific article
Language:
Current Data About Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration
(P31) (Q13442814)
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P50) (Q38544276)
(P1545) 11
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(Q48086375)
(P1545) 14
(P1932) Peter Hillmen

(Q5740316)
(P1932) Herman Waldmann
(P1545) 12

(Q109927200)
(P1545) 1
(P1932) Geoff Hale
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(Q125348788)
(P1545) 8
(P1932) Jeanette Lundin
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(Q125348963)
(P1545) 2
(P1932) Peppy Rebello
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P304) 948-955
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P407) (Q1860)

(P433) 4
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P478) 104
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P577) Thursday, April 15, 2004
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P921) (Q715347)

(Q181600)

(Q29496)
(P887)

(Q1088156)
(P887)

(P1433) (Q885070)
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P1476) "Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration" (language: en)
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

(P2093) Lee R Brettman
(P1545) 3
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Chris Fegan
(P1545) 4
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Ben Kennedy
(P1545) 5
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Eva Kimby
(P1545) 6
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Mike Leach
(P1545) 7
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Håkan Mellstedt
(P1545) 9
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Paul Moreton
(P1545) 10
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

Anders Osterborg
(P1545) 13
(P248)
(P698) 15090452
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/15090452

other details
description scientific article

External Links
(P356) 10.1182/BLOOD-2004-02-0593
(P698) 15090452
(P5875) 8613965